Cohort Profile: The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)

Nina Breinholt Stærke, Joanne Reekie, Isik S. Johansen, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Ole Schmeltz Søgaard, Martin Tolstrup, Kasper Karmark Iversen, Britta Tarp, Fredrikke Dam Larsen, Lykke Larsen, Susan Olaf Lindvig, Inge Kristine Holden, Mette Brouw Iversen, Lene Surland Knudsen, Kamille Fogh, Marie Louise Jakobsen, Anna Traytel, Lars Østergaard, Jens Lundgren, the ENFORCE Study Group
doi: https://doi.org/10.1101/2022.10.09.22280886

Article Information

doi 
https://doi.org/10.1101/2022.10.09.22280886
History 
  • October 10, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Nina Breinholt Stærke1,2,#,
  2. Joanne Reekie3,
  3. Isik S. Johansen4,5,
  4. Henrik Nielsen6,7,
  5. Thomas Benfield8,9,
  6. Lothar Wiese10,
  7. Ole Schmeltz Søgaard1,2,
  8. Martin Tolstrup1,2,
  9. Kasper Karmark Iversen9,11,
  10. Britta Tarp12,
  11. Fredrikke Dam Larsen1,2,
  12. Lykke Larsen4,5,
  13. Susan Olaf Lindvig4,
  14. Inge Kristine Holden4,
  15. Mette Brouw Iversen10,
  16. Lene Surland Knudsen10,
  17. Kamille Fogh11,
  18. Marie Louise Jakobsen3,
  19. Anna Traytel3,
  20. Lars Østergaard1,2,
  21. Jens Lundgren3,
  22. the ENFORCE Study Group*
  1. 1Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
  2. 2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  3. 3Center of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
  4. 4Department of Infectious Diseases, Odense University Hospital, Odense Denmark
  5. 5Department of Clinical Research, University of Southern Denmark, Odense, Denmark
  6. 6Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
  7. 7Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  8. 8Department of Infectious Diseases, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
  9. 9Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
  10. 10Department of Medicine, Zealand University Hospital, Roskilde, Denmark
  11. 11Department of Cardiology and Department of Emergency Medicine, Herlev Hospital, Herlev, Denmark
  12. 12Diagnostic Centre, Silkeborg Regional Hospital, Silkeborg, Denmark
  1. ↵#Correspondence: Nina Breinholt Stærke, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark, Tel +45 78452800, Email : ninase{at}rm.dk
Back to top
Posted October 10, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Cohort Profile: The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)
Nina Breinholt Stærke, Joanne Reekie, Isik S. Johansen, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Ole Schmeltz Søgaard, Martin Tolstrup, Kasper Karmark Iversen, Britta Tarp, Fredrikke Dam Larsen, Lykke Larsen, Susan Olaf Lindvig, Inge Kristine Holden, Mette Brouw Iversen, Lene Surland Knudsen, Kamille Fogh, Marie Louise Jakobsen, Anna Traytel, Lars Østergaard, Jens Lundgren, the ENFORCE Study Group
medRxiv 2022.10.09.22280886; doi: https://doi.org/10.1101/2022.10.09.22280886
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area